McKesson's FoxMeyer purchase $400 mil.-$600 mil. below first bid -- FoxMeyer suit.
This article was originally published in The Tan Sheet
Executive Summary
MCKESSON's FOXMEYER PURCHASE $400-$600 MIL. BELOW FIRST BID, FOXMEYER MAINTAINS in seeking $400 mil. in damages from the wholesaler and 10 drug companies for "a conspiracy of events orchestrated" to drive FoxMeyer's wholesaling business into bankruptcy. In a suit filed Jan. 10 in Dallas state court by holding company FoxMeyer Health, the company alleges that McKesson "led [FoxMeyer] to believe" that it would offer "an amount in the range of $400-$600 mil. for FoxMeyer Health's equity interest in FoxMeyer Corp." in August 1995. FoxMeyer decided to sell off its distribution arm in May 1995.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: